Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
The continuous dopaminergic stimulation provided by infusion of dopamine agonist drugs, is a very effective strategy to control ON-OFF fluctuation in Parkinson's disease. Lisuride is a potent dopamine agonist drug, very soluble in water and can be administered subcutaneously. Many authors have shown that the subcutaneous infusion of lisuride can control fluctuations when applied in combination with oral levodopa as a 24 hour continuous infusion regimen. In this study, lisuride was given without any other antiparkinsonian medicament and using a 12 hour infusion regimen wherever possible. 13 fluctuating Parkinsonian patients were studied. 6 out of these 13 were satisfactory treated with lisuride alone and the remaining 7 with a combination of Lisuride + oral levodopa. Only in 3 out of 13 patients the 24 hour infusion regimen was required.
Stocchi
F
F
Department of Neurology, University of Rome La Sapienza, Italy.
Ruggieri
S
S
Antonini
A
A
Baronti
F
F
Brughitta
G
G
Bellantuono
P
P
Bravi
D
D
Agnoli
A
A
D000284:Administration, Oral; D000328:Adult; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D007980:Levodopa / Q000627:therapeutic use; D008090:Lisuride / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D004873:Ergolines; D007980:Levodopa; D008090:Lisuride